David N. Fass

5.1k citations

89 papers · 3.9k indexed · 1 hit paper · h-index 32

Hematology top 0.2%
Molecular Biology top 10%
Genetics top 1%
Pulmonary and Respiratory Medicine top 5%
Surgery top 10%

Co-authors: E. J. Walter Bowie Pete Lollar Kenneth G. Mann Gaylord J. Knutson Tom Ellenberger M Arnaud Stephen C. Harrison Debra D. Pittman
Topics: Platelet Disorders and Treatments (38 papers)Blood Coagulation and Thrombosis Mechanisms (31 papers)Hemophilia Treatment and Research (26 papers)
Cited by: Hematology Genetics Internal Medicine
Journals: Nature New England Journal of Medicine Proceedings of the National Academy of Sciences
Partner nations: United States Poland Hungary

In The Last Decade

David N. Fass

88 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular cloning of a cDNA encoding human antihaemophilic factor

1984 731 citations David N. Fass et al. profile →

Peers

Countries citing papers authored by David N. Fass

Since Specialization

Citations

This map shows the geographic impact of David N. Fass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David N. Fass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David N. Fass more than expected).

Fields of papers citing papers by David N. Fass

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David N. Fass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David N. Fass. The network helps show where David N. Fass may publish in the future.

Co-authorship network of co-authors of David N. Fass

This figure shows the co-authorship network connecting the top 25 collaborators of David N. Fass. A scholar is included among the top collaborators of David N. Fass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David N. Fass. David N. Fass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The “normal” factor VIII concentration in plasma 2010 ·Thrombosis Research ·Saulius Butenas,Behnaz Parhami-Seren,Anetta Undas,David N. Fass,Kenneth G. Mann	19
2	Functional Significance of Asn-linked Glycosylation of Proteinase 3 for Enzymatic Activity, Processing, Targeting, and Recognition by Anti-neutrophil Cytoplasmic Antibodies 2006 ·The Journal of Biochemistry ·Ulrich Specks,David N. Fass,Javier D. Finkielman,Amber M. Hummel,Margaret A. Viss,Robert D. Litwiller,Charles J. McDonald	14
3	Differences between human proteinase 3 and neutrophil elastase and their murine homologues are relevant for murine model experiments 2005 ·FEBS Letters ·Olaf Wiesner,Robert D. Litwiller,Amber M. Hummel,Margaret A. Viss,(unknown),Dieter E. Jenne,David N. Fass,Ulrich Specks	52
4	Atrial fibrillation and thrombosis: immunohistochemical differences between in situ and embolized thrombi 2004 ·Journal of Thrombosis and Haemostasis ·Waldemar E. Wysokiński,Whyte G. Owen,David N. Fass,(unknown),Linda Murphy,Robert D. McBane	52
5	Effects of carboxy-terminal modifications of proteinase 3 (PR3) on the recognition by PR3-ANCA 2003 ·Kidney International ·Stephen A. Capizzi,Margaret A. Viss,Amber M. Hummel,David N. Fass,Ulrich Specks	19
6	Categorization Under Complexity: A Unified MDL Account of Human Learning of Regular and Irregular Categories 2002 ·Neural Information Processing Systems ·David N. Fass,Jacob Feldman	13
7	A Study of a Weight-Adjusted Aprotinin Dosing Schedule During Cardiac Surgery 2002 ·Anesthesia & Analgesia ·Gregory A. Nuttall,David N. Fass,Lance J. Oyen,William C. Oliver,Mark H. Ereth	16
8	Plasma Aprotinin Concentrations During Cardiac Surgery: Full- Versus Half-Dose Regimens 2000 ·Anesthesia & Analgesia ·(unknown),Gregory A. Nuttall,David N. Fass,William C. Oliver,Mark H. Ereth,Lance J. Oyen	37
9	Capture-ELISA based on recombinant PR3 is sensitive for PR3–ANCA testing and allows detection of PR3 and PR3–ANCA/PR3 immunecomplexes 1998 ·Journal of Immunological Methods ·(unknown),David N. Fass,(unknown),Margaret A. Viss,Jörgen Wieslander,Henry A. Homburger,Ulrich Specks	58
10	Factor VIII Structure and Function 1991 ·Annals of the New York Academy of Sciences ·David N. Fass	6
11	Degradation of coagulation proteins by an enzyme from Malayan pit viper (Akistrodon rhodostoma) venom 1987 ·Biochemistry ·Pete Lollar,Carlo Parker,(unknown),Robert D. Litwiller,David N. Fass	24
12	The capillary thrombometer and von willebrand factor 1987 ·Thrombosis Research ·(unknown),(unknown),Y. Sawada,David N. Fass,J A Katzmann,E. J. Walter Bowie	1
13	Experimental Porcine Infective Endocarditis: Description of a Clinical Model 1986 ·Veterinary Pathology ·Christopher M. Johnson,R. C. Bahn,David N. Fass	11
14	The role of Willebrand factor in platelet — blood vessel interaction, including a discussion of resistance to atherosclerosis in pigs with von Willebrand’s disease 1981 ·Philosophical transactions of the Royal Society of London. Series B, Biological sciences ·E. J. Walter Bowie,Valentı́n Fuster,David N. Fass,C. A. Owen	8
15	Hemostatic Effect of Transfused Willebrand Factor in Porcine von Willebrand’s Disease 1980 ·Pathophysiology of Haemostasis and Thrombosis ·E. J. Walter Bowie,David N. Fass,C. A. Owen	15
16	Reduced Polymerization of Willebrand Factor in a Family of Pigs with a Variant of von Willebrand’s Disease 1977 ·Thrombosis and Haemostasis ·David N. Fass,E. J. Walter Bowie	2
17	Cultured Normal and von Willebrand Porcine Aortic Endothelial Cells-An in Vitro Model for Studying the Nature and Site of Platelet-Endothelial Component Interaction 1977 ·Thrombosis and Haemostasis ·François M. Booyse,David N. Fass,E. J. Walter Bowie	1
18	The Interaction of the Platelet and von Willebrand Factor 1977 ·Thrombosis and Haemostasis ·David N. Fass,François M. Booyse,JC Lewis,E. J. Walter Bowie	3
19	The Spectrum of von Willebrand’s Disease Revisited 1976 ·Mayo Clinic Proceedings ·E. J. Walter Bowie,David N. Fass,John D. Olson,C. A. Owen	10
20	Tests of Hemostasis in Swine: Normal Values and Values in Pigs Affected with von Willebrand's Disease 1973 ·American Journal of Veterinary Research ·E. J. Walter Bowie,Charles A. Owen,Paul E. Zollman,John H. Thompson,David N. Fass	17

About David N. Fass

David N. Fass is a scholar working on Hematology, Genetics and Immunology and Allergy, having authored 89 papers that have together received 3.9k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (38 papers), Blood Coagulation and Thrombosis Mechanisms (31 papers) and Hemophilia Treatment and Research (26 papers). The work is most often cited by research in Hematology (2.3k citations), Genetics (737 citations) and Internal Medicine (172 citations). David N. Fass has collaborated with scholars based in United States, Poland and Hungary. Frequent co-authors include E. J. Walter Bowie, Pete Lollar, Kenneth G. Mann, Gaylord J. Knutson, Tom Ellenberger, M Arnaud, Stephen C. Harrison, Debra D. Pittman, Randal J. Kaufman and Charles M. Heldebrant. Their work appears in journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact